Abstract
Introduction

1
Genome wide association studies (GWAS) have identified thousands of genomic loci 2 associated with complex traits and diseases (https://www.ebi.ac.uk/gwas/). However, 3 identification of the causal mechanisms underlying these associations and subsequent 4 biological insights have not been as forthcoming, due to issues such as linkage disequilibrium 5 (LD) and incomplete genomic coverage. One approach to aid biological insight following 6 GWAS is to make use of functional data. For example, candidate causal genes can be proposed 7 when the overlap in association signals between a complex trait and functional data (e.g. gene 8 expression) is a consequence of both traits sharing a causal variant, i.e. the association signals 9
for both traits colocalize. The abundance of significant associations identified by GWAS means 10 that chance overlap between association signals for different traits is likely 1 . Consequently, 11 overlap does not by itself allow us to identify causal variants 1,2 . Statistical colocalization 12 methodologies seek to resolve this. By constructing a formal statistical model, colocalization 13 approaches have been successful in identifying whether a molecular trait (e.g. gene expression) 14 and a disease trait share a causal variant in a genomic region [3] [4] [5] [6] [7] , and potentially prioritise a 15 candidate causal gene. Recently it has been proposed that colocalization methodologies can be 16 further enhanced by integrating additional information from multiple intermediate traits linked 17 to disease, e.g. protein expression, metabolite levels 8 . The underlying hypothesis of multi-trait 18 colocalization is that if a variant is associated with multiple related traits then this provides 19 stronger evidence that the variant may be causal 8 . Thus, multi-trait colocalization aims to 20 increase power to identify causal variants. We show that by using multi-level functional datasets 21 in this way can reveal candidate causal genes and pathways underpinning complex disease. 22
A number of statistical methods have been developed to assess whether association signals 23 across a pair of traits colocalize [3] [4] [5] [6] [7] . These methods predominantly assess colocalization 24 between a pair of traits using individual participant data 9,10 , limiting their applicability. In 25 contrast, the COLOC algorithm uses GWAS summary statistics 2 . This approach works by 1 systematically exploring putative "causal configurations", where each configuration locates a 2 causal variant for one or both traits, under the assumption that there is at most one causal variant 3 per trait. COLOC was recently extended to the multi-trait framework, MOLOC 8 . The authors 4 achieved a 1.5-fold increase in candidate causal gene identification when a third relevant trait 5 was included in colocalization analyses relative to results from two traits. However, the 6 approach is computationally impractical beyond 4 traits due to prohibitive computational 7 complexity arising from the exponential growth in the number of causal configurations that 8 must be explored with each additional trait analysed. 9
Here we present a computationally efficient method, Hypothesis Prioritisation in multi-trait 10 Colocalization (HyPrColoc), to identify colocalized association signals using summary 11 statistics on large numbers of traits. The approach extends the underlying methodology of 12 COLOC and MOLOC. Our major result is that the posterior probability of colocalization at a 13 single causal variant can be accurately approximated by enumerating only a small number of 14 putative causal configurations. Moreover, HyPrColoc is able to identify subsets (which we 15 refer to as clusters) of traits which colocalize at distinct causal variants in the genomic locus by 16 employing a novel branch and bound divisive clustering algorithm. We applied HyPrColoc 17 genome-wide to coronary heart disease (CHD) and many related traits 11, 12 , to identify genetic 18 risk loci shared across these traits. 19
Results
20
Overview
21
HyPrColoc is a Bayesian method for identifying shared genetic associations between complex 22 traits in a particular gene region using summary GWAS results. HyPrColoc provides two 23 principal novelties: (i) Efficient computation of the posterior probability that all m traits sharea causal variant (which we refer to as the posterior probability of full colocalization, PPFC); 1 and (ii) partitioning of traits into clusters, such that each cluster comprises traits sharing a causal 2 variant. HyPrColoc only requires regression coefficients and their corresponding standard 3 errors from summary GWAS (for binary traits these can be on the log-odds scale, Methods). 4
The approach makes three key assumptions: (i) for non-independent studies, that the GWAS 5 results are from the same underlying population, i.e. that the LD pattern is the same across 6 studies, (ii) that there is at most one causal variant in the genomic region for each trait (we 7 assess limitations of this assumption when there are multiple underlying variants in the 8 Discussion/Supplementary Material), and (iii) that these causal variants are either directly 9 typed or well imputed in all of the GWAS datasets 2, 8 . 10
Description of the HyPrColoc method
11
We define a putative causal configuration matrix to be a binary × matrix, where is 12 the number of traits and is the number of variants.
is 1 if the ℎ variant is causal for the 13 ℎ trait and 0 otherwise (Supplementary Material). A hypothesis uniquely identifies traits 14 which share a causal variant, traits which have distinct causal variants and traits which do not 15 have a causal variant. Except for the null hypothesis ( 0 ) of no causal variant for any trait, 16 hypotheses such as "
: all traits share a causal variant" correspond to multiple 17 configuration matrices, (Figure 1) . By considering the set of configurations to which a 18 hypothesis corresponds, the posterior odds of the hypothesis against the null hypothesis can be 19 computed. For example, let denote the set of configurations for hypothesis and 0 20 denote the single configuration for 0 , then the posterior odds for the hypothesis that all traits 21 colocalize to a single causal variant is given by, 22
where represents the combined trait data, the first term in the summation is a Bayes factor 1 and the second term is a prior odds 2, 8 . To identify a candidate causal variant across the traits, 2 i.e. to perform multi-trait fine-mapping, we locate the configuration * satisfying 3 max ∈ ( | ) = ( * | ). If the summary data for the genetic associations between traits are 4 independent, then the Bayes factor for each configuration can be computed by combining 5
Wakefield's approximate Bayes factors 13 for each trait in the configuration (Methods). If the 6 summary data between traits are correlated because a subset of the participant data was used in 7 at least two of the GWAS analyses, then an extension to Wakefield's approximate Bayes 8 factors, which jointly models the trait associations, can be employed (Methods). For a given 9 hypothesis and set of corresponding configurations , the prior probability of configuration 10 , ( ), can either be equal for all ∈ , or can be defined as a product of variant-level priors 11 (Methods). Our variant-level prior extends that of COLOC 2 and MOLOC 8 to a framework that 12 is suitable for the analysis of large numbers of traits. This approach requires specification of 13 only two interpretable parameters: , the probability that a variant is causal for one trait, and , 14 where 1 − is the conditional probability that a variant is causal for a second trait given it is 15 causal for one other trait (Methods). 16
Efficient computation of PPFC
17
For a pre-specified genomic region comprising variants, the aim is to evaluate the , 18 ( | ), that all traits share a causal variant within that region, given the summarized data 19
. According to Bayes' rule, this is given by: 20
Brute-force computation of the denominator, ( ), requires the exhaustive enumeration of 22 ( + 1) causal configurations, which is computationally prohibitive for > 4 , e.g. 23
MOLOC
8 . HyPrColoc overcomes this challenge by approximating ( ) in a way that is both 1 computationally efficient and tightly bounds the approximation error. 2
As we show in the Methods, the PPFC can be approximated as 3
where , > 0 are rapidly computable values that quantify the probability that two criteria 5 necessary for colocalization are satisfied (Figure 2) . The first of these criteria is that all the 6 traits must share an association with one or more variants within the region. , which we refer 7 to as the regional association probability, is the probability that this criterion is satisfied. By 8 itself, this criterion does not guarantee that there is a single causal variant shared by all traits, 9 because it could be the case that two or more traits have distinct causal variants in strong LD 10 with one another. To safeguard against this, we have a second criterion that ensures the shared 11 associations between all traits are owing to a single shared putative causal variant. is the 12 probability that this second criterion is satisfied. We refer to as the alignment probability as 13 it quantifies the probability of alignment at a single causal variant between the shared 14 associations. Both and have linear computational cost in the number of traits , making 15 a calculation of ̂ possible when analysing vast numbers of traits. If the first criterion is 16 satisfied, but the second is not, this may be because it is possible to partition the traits into 17 clusters, such that each cluster has a distinct causal variant. HyPrColoc additionally seeks to 18 identify these clusters. 19
Identification of clusters of colocalized traits
20
If ̂ falls below a threshold value, , we reject the hypothesis that all m traits colocalize 21 to a shared causal variant. In practice, this threshold is specified by defining separate 22 thresholds, * and * , for and , such that = * * (Methods). If is rejected, 23 there exist subsets of the traits such that all traits within the same subset colocalize to a shared 1 causal variant. Starting with a single cluster containing all traits, our branch and bound 2 divisive clustering algorithm (Figure 3) iteratively partitions the traits into larger numbers of 3 clusters, stopping the process of partitioning a cluster of two or more traits when all traits in a 4 cluster satisfy both > * and > * . The process of partitioning a cluster into two smaller 5 clusters is performed using one of two criteria: (i) regional ( ) or (ii) alignment ( ) selection 6 (Methods and Supplementary Note). For ≤ traits in a cluster, the regional selection 7 criterion has ( ) computational cost and is computed from a collection of hypotheses that 8 assume not all traits in a cluster colocalize because one of the traits does not have a causal 9 variant in the region. The alignment selection criterion has ( 2 ) computational cost and is 10 computed from hypotheses that assume not all traits in a cluster colocalize because one of the 11 traits has a causal variant elsewhere in the region (Supplementary Note). By default, the 12 HyPrColoc software uses the more computationally efficient regional selection criterion to 13 partition a cluster. 14
Model validation using simulations
15
We created simulated datasets by resampling phased haplotypes from the European samples in 16 1000 Genomes 14 and for each dataset we randomly selected one of the first 50 regions 17 confirmed to be associated with CHD 15 (Methods). For each simulation scenario, 1,000 18 replicates were performed. 19
Computational efficiency
20
The posterior probability of colocalization, across traits and in a region of variants, can be 21 accurately approximated by computing ( 2 ) causal configurations. Figure 4 illustrates this 22 for varying numbers of independent studies and variants, demonstrating a close linear 23 relationship between computation time and the number of traits. Consequently, HyPrColoc is 24 able to assess 100 traits, in a region of 1,000 SNPs, in under 1 second compared to MOLOC 1 which takes approximately one hour to analyse five traits. For ≤ 4, traits the median absolute 2 relative difference between the HyPrColoc and MOLOC 8 posterior probabilities was found to 3 be ≲ 0.5% (Figure 4) . 4
Performance of HyPrColoc to detect multi-trait colocalization
5
We used simulated datasets in which all traits colocalize to assess the accuracy of HyPrColoc 6 in detecting colocalization across varying numbers of traits and study sample sizes. We 7 simulated independent datasets with sample sizes of 5,000, 10,000, and 20,000 individuals for 8 up to 100 quantitative traits and for which all traits share a single causal variant explaining 9 either 0.5%, 1% or 2% of trait variance. For each simulated dataset, we used HyPrColoc to 10 approximate the PPFC. The distribution of PPFC across the simulated datasets was narrower 11 in the analysis of two traits relative to a larger number of traits, as the probability of random 12 misalignment of the lead variant between traits increases as the number of traits increases (top 13 Figure 5 ). However, the estimated PPFC is always close to 1 for 5, 10 and 20 traits illustrating 14 that the distribution of the estimate is stable across a broad number of traits and sample sizes. 15
For 100 traits there is a small decrease in power due to the growth in the number of hypotheses 16 in which only a subset of the traits colocalize. This is expected when sample size is fixed and 17 the shared causal variant explains only a small fraction of trait variation for each trait, as 18 combined evidence supporting hypotheses in which a subset of the traits colocalize are 19 eventually greater than evidence supporting full colocalization. 20
When at least one trait did not have a causal variant in the region the false detection rate was 21
negligible. For example, we generated 100 quantitative traits, each from a study with sample 22 size 10,000, in which 99 traits share a causal variant and the remaining trait had either: (i) a 23 distinct causal variant or (ii) no causal variant in the region. In each scenario a causal variant 24 explained 1% of trait variation. The 1 st , 5 th (median) and 9 th deciles of the PPFC were 25 scenarios, the causal variant for each trait explained 1% of trait variance and the probability 22 parameters were set to * = * = 0.6 (Methods). HyPrColoc correctly identified the cluster 23 or clusters of colocalized traits with probability ≈ 0.95 in all simulation scenarios. However, 24 owing to the large number of traits analysed and strong LD between distinct causal variants 1 these clusters occasionally wrongly included one additional trait. To provide insight into when 2 this happens, in each scenario we stratified results into two categories: (a) > 0.6 and (b) 3 > 0.7, where denotes the posterior probability that a cluster of traits are identified 4 as colocalizing. In scenario (iii) we additionally stratified according to LD between causal 5 variants: (a) 2 ≤ 1 and (b) 2 < 0.95. Across all scenarios, the probability of identifying the 6 true cluster(s) of colocalized traits was higher for larger . For example, in scenarios (i) and 7
(ii) when > 0.7 the BB algorithm identifies the true cluster(s) of colocalized traits with 8 probability ≳ 0.9, whereas for > 0.6 the true detection probability was lower but still > 9 0.8. When many traits have a distinct causal variant, scenario (iii), the probability of detecting 10 the true cluster of colocalized traits dropped markedly (≈ 0.7). This was due to the increased 11 chance that the causal variant from a non-colocalized trait is in strong LD with the colocalized 12 causal variant, i.e.
2 ≥ 0.95, a scenario in which no algorithm is likely to perform well. In 13 scenarios where 2 < 0.95, for all causal variants, the true detection probability was ≳ 0.9. We 14 found an increase in the true detection probabilities of the BB algorithm when analysing 20 15 traits under a similar simulation framework (Supplementary Material, Figure S2 ), indicating 16 that the performance of the algorithm is somewhat dependent upon the number of traits under 17 consideration. Overall, across the range of scenarios considered the selection algorithm 18 performs well in terms of sensitivity and specificity. 19
We further tested the algorithm using a variety of thresholds { * , * }, two different prior 20 frameworks and accounting for overlapping samples in analyses ( Figures S4-5 ). We 21 demonstrated that treating studies as independent, even when there is complete sample overlap 22 (i.e. participants are the same in all studies) gives reasonable results ( Figure S3 ). We discuss 23 the theoretical reasons for this in Supplementary Material. We also assessed the reliability of 24 the BB algorithm when a secondary causal variant was added to one or more traits in the region. Table  5 S1 for details). We performed colocalization analyses in pre-defined disjoint LD blocks 6 spanning the entire genome 24 . To highlight that multi-trait colocalization analyses can aid 7 discovery of new disease-associated loci, we used the CARDIoGRAMplusC4D 2015 data for 8 CHD 16 , which brought the total number of CHD associated regions to 58, and contrasted our 9 findings with the current total of ~160 CHD associated regions 25 . For each region in which 10 CHD and at least one related trait colocalized, we integrated whole blood gene expression 26 11 quantitative trait loci (eQTL) and protein expression 27 quantitative trait loci (pQTL) 12 information into our analyses to prioritise candidate causal genes (Methods). 13
Multi-trait colocalization
14
Our genome-wide analysis identified 43 regions in which CHD colocalized with one or more 15 related traits (Figure 7 and Table 1 ). Twenty-three of the 43 colocalizations involved blood 16 pressure, consistent with blood pressure being an important risk factor for CHD 28 . Other traits 17 colocalizing with CHD across multiple genomic regions were cholesterol measures (16 18 regions); adiposity measures (9 regions); type 2 diabetes (T2D; 4 regions) and; rheumatoid 19 arthritis (2 regions). Moreover, by colocalizing CHD and related traits, our analyses suggest 20 these traits share some biological pathways. 21
In thirty-eight of the 43 (88%) colocalized regions 15, 16, 25, [29] [30] [31] [32] [33] [34] , the candidate causal SNP 22
proposed by HyPrColoc and/or its nearest gene, have been previously identified. Importantly, 23 20 of these were reported after the CARDIoGRAMplusC4D study 16 . For example, FGF5 was 24 sub-genome-wide significant (P>5x10 -8 ) with CHD in the 2015 data, but through colocalization 1 with blood pressure, we highlight it as a CHD locus and it is genome-wide significant in the 2 most recent CHD GWAS 25 . The remaining 18 regions were reported previously, but one, 3 APOA1-C3-A4-A5, was sub-genome-wide significant in the CARDIoGRAMplusC4D study 16 4 despite having been reported previously 34 . However, we used HyPrColoc to show that the 5 association of major lipids colocalize with a CHD signal, highlighting this as a CHD locus in 6 these data ( Table 1 and Figure S6 ). The locus has subsequently been replicated 25, 30 and we 7
show below that the signal also colocalizes with circulating apolipoprotein A-V protein levels 8 (Table 1) . This demonstrates that joint colocalization analyses of diseases and related traits can 9 improve power to detect new associations (an approach which is advocated outside of 10 colocalization studies 35 ). Our results also illustrate that multi-trait colocalization analyses can 11 provide further insights into well-known risk-loci of complex disease. For example, at the well-12 studied SH2B3-ATXN2 region 25, 34 , HyPrColoc detected two cholesterol measures (LDL, HDL), 13 two blood pressure measures (SBP, DBP) and rheumatoid arthritis (RA) colocalizing with CHD 14 at the previously reported CHD associated SNP 25 rs7137828 (PPFC=0.909 of which 76.8% is 15 explained by the variant rs7137828; Figure 7 ). In addition, we newly implicated a candidate 16 SNP and locus in a further 5 CHD regions not previously associated with CHD risk (Table 1) . 17
In one of the 5 regions, CYP26A1, CHD colocalized with tri-glycerides (TG) and HyPrColoc 18 identified a single variant that explained over 75% of the posterior probability of colocalization, 19 supporting this SNP as a candidate shared CHD/TG variant. 20
For each of the 43 regions that shared genetic associations across CHD and related traits, we 21 further integrated whole blood gene 26 and protein 27 expression into the colocalization analyses. 22
We tested cis eQTL for 1,828 genes and cis pQTL from the 854 published proteins across the 23 43 loci for colocalization with CHD and the related traits. Of the 43 listed variants (Table 1) , 24 27 were associated with expression of at least one gene (P<5x10 -8 ) and a total of 125 such genes 25 were identified. HyPrColoc refined this, identifying six regions colocalizing with eQTL for one 1 expressed gene and one region, the FHL3 locus, colocalizing with expression of three genes 2 (SF3A3, UTP11L, RNU6-510P) ( Table 1) . The GUCY1A3 locus has previously been associated 3 with BP 36 and with CHD 15 . Here we show that these associations are likely to be due to the 4 same variant, rs72689147 (PPFC=0.93), with the G allele increasing DBP and risk of CHD. We 5 furthermore show that the association colocalizes with expression of GUCY1A1 in whole blood, 6
with the G allele reducing GUCY1A1 expression (PPFC=0.77; Table 1 ). The GUCY1A1 gene 7 is ubiquitously expressed in heart tissues, including in the coronary and aortic arteries 37 . In the 8 mouse, higher expression of GUCY1A1 has been correlated with less atherosclerosis in the 9 aorta 38 . GUCY1A1 is a likely candidate gene in this locus 39 , illustrating the utility of HyPrColoc 10 to help prioritise candidate causal genes. The CTRB2-BCAR1 locus was not known at the time 11 of the release of the 2015 CARDIoGRAMplusC4D data, however we find the association at 12 this locus is shared with T2D (PPFC=0.83) and that BCAR1 expression colocalized with the 13 CHD association (PPFC=0.86). Other studies have implicated the locus in CHD 33 and suggested 14 BCAR1 as the causal gene in carotid intimal thickening 40, 41 . We note that two CHD loci also 15 colocalize with circulating plasma proteins, APOA1-C3-A4-A5, with apolipoprotein A-V and 16 the APOE locus with apolipoprotein E (Table 1) We have developed and applied a deterministic Bayesian colocalization algorithm, HyPrColoc, 2 for multi-trait statistical colocalization analyses. HyPrColoc is based on the same underlying 3 statistical model as COLOC 2 , but for the first time enables colocalization analyses to be 4 performed across massive numbers of traits, owing to the novel insight that the posterior 5 probability of colocalization at a single causal variant can be accurately approximated by 6 enumerating only a small number of putative causal configurations. The HyPrColoc algorithm 7 was validated using simulations and used to assess genetic risk shared across CHD and related 8 traits. Using CHD data from 2015 16 , in which 46 regions were genome-wide significant 9 (P<5x10 -8 ), our multi-trait colocalization analysis identified 43 regions in which CHD 10 colocalized with ≥1 related trait. With this approach, we were able to identify CHD loci that 11
were not known at the time of the data release (2015), demonstrating the benefit of synthesising 12 data on related traits to uncover potential new disease-associated loci 8, 35 . A further five regions, 13 we postulate, may be identified as CHD loci in the future. Others have considered pleiotropic 14 effects of CHD loci previously 42 , but our formal colocalization analyses are more robust, e.g. 15 in the ABO region we show colocalization of T2D and DBP in addition to the previously 16 reported pleiotropic effect with LDL. We integrated eQTL and pQTL data to prioritise 17 candidate genes at some loci, e.g. GUCY1A1, BCAR1 and APOE. 18
The HyPrColoc algorithm identifies regions of the genome where there is evidence of a shared 19 causal variant (by dissecting the genome into distinct regions) and also allows for a targeted 20 analysis of a specific genomic locus of primary interest, e.g. when aiming to identify the 21 perturbation of a biological pathway through the influence of a particular gene. Moreover, these 22 region-specific analyses can highlight candidate causal genes, which will help improve 23 biological understanding and may indicate potential drug targets to inform medicines 24 development 43 . 25
We have described HyPrColoc under the assumption of at most one causal variant per trait. 1 Future work is required to extend this methodology and algorithm to multiple-causal variants. 2 However, we note that the reliability of results under the single causal variant assumption only 3 break down when secondary causal variants explain as much trait variation as the shared variant 4 (Supplementary Material). An example of which is the expression of SH2B3, where multiple 5 causal variants for the expression of this gene masks colocalization with the CHD signal. We 6 note that misspecification of LD between causal variants has a major impact on correct 7 detection of multiple causal variants in a region 44 , making a single causal variant assessment 8 the most reliable when accurate study-level LD information is not available. To overcome 9 challenges when specifying the prior probability of a causal configuration, we have suggested 10 two different parsimonious configuration priors that allow a sensitivity analysis to the type of 11 prior and the choice of hyper-parameters to be performed (Methods). Nevertheless, other priors 12 may be more appropriate for particular applications. 13
In summary, we have developed a computationally efficient method that can perform multi-14 trait colocalization on a large scale. As the size and scale of available data on genetic 15 associations with traits increase, computationally scalable methods such as HyPrColoc will be 16 increasingly valuable in prioritizing causal genes and revealing causal pathways. 17
Software availability
18
We developed an R package for performing the HyPrColoc analyses 19 (https://github.com/jrs95/hyprcoloc). The regional association plots (as seen in Figure 7) were 20 created using gassocplot (https://github.com/jrs95/gassocplot) and LD information from 1000 21 Nature 526, 68-74 (2015) . 
Methods
1
SNP association models
2
Let denote one of = 1,2, … , , traits assessed in a maximum of studies, i.e. two or more 3 traits can be measured in the same study, and denote the genotype of the th genetic variant. 4
It is assumed that the outcome model for is given by 5
where is the intercept term and ℎ is a function linking the ℎ outcome to the genotype , 7 for all = 1,2, … , genetic variants in the genomic region. The function ℎ is typically taken 8 as the identity function for continuous traits and the logit function for binary traits. The aim of 9 colocalization analyses is to identify genomic loci where there exists an that is causally 10 associated with at least two of the traits. For each of the traits and genetic variants, we 11 assume that GWAS summary statistics ̂ and var(̂) are available. We use these data to 12 perform colocalization analyses in genomic loci. 13
Colocalization posterior probability
14
Using binary vectors to indicate whether a variant putatively causally influences a trait, we can 15 define causal configurations ( ) that can be grouped into sets ( ) which belong to a single data 16 generating hypothesis ( ). We use the notation ℋ ( , ,… ) to denote a set of hypotheses in which 17 a collection of traits share a causal variant, a separate collection of traits share a distinct 18 causal variant, and so on (Figure 1) . For, example, ℋ (2,1) denotes the set of hypotheses in 19 which each hypothesis specifies uniquely 2 traits that share a causal variant, a single trait has a 20 distinct causal variant and all remaining − 3 traits do not have a causal variant in the region. 21
Assuming at most one causal variant for each trait these data generating hypotheses can be 22 combined to generate a hypothesis space (Ω). The posterior probability of hypothesis , given 23 the combined data from all studies, can therefore be computed using (Supplementary 1
where ( )/ ( 0 ) is the prior-odds of configuration ∈ compared with the null-3 configuration 0 , i.e. no genetic association with any trait. See 2 for a derivation with = 2 4 traits.
( ) is a Bayes factor which is the likelihood of the data being generated under ∈ 5 relative to the likelihood of the data being generated 0 . 6
Computing Bayes Factors: independent studies
8 If the trait associations are calculated using independent studies (i.e. no overlapping samples in 9 the GWAS datasets), the Bayes factors can be computed using Wakefield's Approximate Bayes 10 where , and are the Z-statistic, standard error and the prior standard deviation for ̂, 13 respectively. Following 2 , for continuous variables is set to 0.15 while for binary traits it is 14 set to 0.2. As an example, the for the hypothesis that all traits colocalize at genetic 15 variant ( ∈ ) is given by, 16
Calculating Bayes Factors: non-independent studies 18
If the trait associations are not calculated using independent studies i.e. there are overlapping 1 samples, the Bayes factor for each causal configuration can be computed using a Joint 2 ( ) (Supplementary Material). The for causal configuration is given by, 3
where ̂ is the vector of regression coefficients for all traits, Σ̂ is an × variance-5 covariance matrix of the regression coefficients (i.e. ̂, where 2 is a diagonal matrix of 6 variances for the regression coefficients, e.g. with th diagonal element • 2 , and ̂ is the 7 observed correlation matrix for the regression coefficients) and Σ is the 'adjusted' prior 8 variance-covariance matrix (i.e. ̃̃, where ̃ is a diagonal matrix of prior variance 9 divided by estimated variance, e.g. with th diagonal element • 2 / • 2 , and is the prior 10 correlation matrix between traits). The correlation matrix (̂) is computed using the tetrachoric 11 correlation method 45 and we discuss our approach to setting in the Supplementary Material. 12
Configuration prior probabilities
13
We consider two different strategies for determining the priors for different hypotheses: variant-14 level priors and uniform priors. 15
Variant-level prior probabilities 16
The prior probability space for a single genetic variant can be fully partitioned into the prior 17 probability that the genetic variant is not associated with any of the traits, 0 , the prior 18 probability that the genetic variant is associated with only the first trait, 1 ,…, the prior 19 probability that the SNP is associated with a subset of traits { 1 , 2 , … , }, 1 2 … , …, the 20 prior probability that the genetic variant is associated with all traits, 12… . Hence, 21
Following 2,8 we set that the prior probability to not vary by genetic variant, nor by the specific 2 collection of colocalized traits of a given size, but by the number of colocalized traits, i.e. a 3 SNP associated with a total of traits has a prior probability that depends on the number but 4 not the specific collection of traits. To allow for the assessment of large numbers of traits we 5 propose variant-level priors where the prior probability that a genetic variant is associated with 6 traits is given by, 7
where is the probability of the genetic variant being associated with one trait and is a 9 parameter which controls the probability that a genetic variant is associated with an additional 10 trait. Notably, 1 − is the probability of a variant being causal for a second trait given it is 11 causal for one trait, 1 − 2 is the probability it is causal for a third trait given it is causal for 12 two traits, and so on. It follows that, 13 Material). For example, if the first traits are believed to share a causal variant a priori, then 1 the prior probability that the ( + 1) ℎ is also colocalized, conditional on the other traits, 2 increases as the number of colocalized traits grows. The marginal prior probability of traits 3 colocalizing is always very small, however, which controls the false positive rate (Figures 6  4   and S3; Supplementary Tables S2-3) . Conditional growth limits the loss of power when 5 assessing colocalization across a large number of traits. A loss in power necessarily occurs 6 when analysing large numbers of colocalized traits, due to the rapid growth in the number of 7 hypotheses in which a subset of traits can colocalize relative to all traits colocalizing. Evidence 8 supporting these 'subset' hypotheses will eventually overwhelm evidence in favour of the 9 maximum number of truly colocalized traits for fixed sample size ( Figure 5A) . 10
Conditionally uniform prior probabilities 11
An alternative prior strategy is to assume uniform priors for each configuration within a 12 hypothesis 46 . This strategy benefits from: (i) not setting variant-level information and (ii) 13 implicitly accounting for large differences in the causal configuration space between 14 hypotheses, which limits the loss in power of the PPFC for very large . These priors take the 15 form, 16
where | ℋ | = and 18 The HyPrColoc posterior is computed in two steps.
Step 1 computes the regional association 13 probability , defined as: 14
Step 2 computes the alignment probability , defined as: 16
Note that is computed using ( + 1) causal configurations and is computed using an 18 additional ( − 1) causal configurations. Hence, computation of and has ( 2 ) 19 computational cost. We let = − − ( −1,1) , then it follows that the posterior 20 probability of all traits sharing a single causal variant is given by 21 together the regional and alignment probabilities when multiplied form a statistic that is 9 sufficient to accurately assess evidence of the full colocalization hypothesis. The objects 10 and can be defined for various collections of hypotheses that partition . However, the 11 major insight is that the hypotheses contained in and are computed with minimal 12 computation burden, i.e. computed using ≤ 2 causal configurations, amongst all 13 alternatives, making the HyPrColoc approximation tractable for very large numbers of traits . 14 Our software allows for the assessment of the HyPrColoc approximation by increasing the 15 number of hypotheses used to approximate , e.g. we can compute 16 To identify complex patterns of colocalization amongst all traits, we propose a branch and 6 bound (BB) divisive clustering algorithm that utilizes the HyPrColoc approximation to identify 7 a cluster of traits with the greatest evidence of colocalization at each iteration (Figure 3 and  8 
Supplementary Material).
Starting with all of the traits in a single cluster, the algorithm 9 explores evidence supporting any of 2 branches -a branch represents a hypothesis whereby 10 − 1 traits share a causal variant and either the remaining trait does not have a causal variant 11 or has a causal variant elsewhere in the region -against the full colocalization hypothesis. These 12 branches represent the hypotheses used in the computation of the regional and alignment 13 probabilities and . There are two bounds: (i) the minimum probability required to accept 14 evidence that all traits are regionally associated * and (ii) the minimum probability required 15 to accept that the causal variant for all traits aligns at a single variant * . The BB algorithm 16 accepts evidence supporting all traits sharing a single causal variant if ≥ * * , after 17 which the algorithm returns the HyPrColoc estimate of and stops. If either < * or 18 < * there is insufficient evidence supporting all traits sharing a causal variant and the BB 19 algorithm moves to the branch with maximum evidence supporting − 1 traits sharing a 20 causal variant. At this point the traits are partitioned into two clusters: one containing − 1 21 traits deemed most likely to share a causal variant and a second cluster containing the remaining 22 trait. We repeat this process of branch selection and partitioning on the cluster of − 1 traits 23 until we identify either: (A) a cluster of traits of size ≥ 2 whose regional and alignment 24 statistics satisfy ≥ * * , or (B) there is one trait left in the cluster. In scenario A, theHyPrColoc posterior probability that all traits colocalize is presented and the remaining − 1 traits are assessed for evidence of colocalization using the branch selection and partitioning 2 scheme. In scenario B, the trait is deemed not colocalize with any other trait in the sample and 3 the BB selection algorithm is repeated using − 1 traits. The entire process is repeated until 4 all clusters of colocalized traits, whereby each cluster of traits colocalize at a distinct causal 5 variant, have been identified, all other traits are deemed not to share a causal variant with any 6 other trait. 7
Simulation study 8
To create genomic loci with realistic patterns of LD, for each simulation scenario we simulated 9 1,000 datasets and for each dataset we resampled phased haplotypes from the European samples 10 in 1000 Genomes 14 and randomly chose one of the first 50 regions confirmed to be associated 11 with CHD 15 . Unless stated otherwise, for traits that have a causal variant in the region, the 12 variant explains 1% of trait variance and each trait was assumed to be measured in studies with 13 a sample size of = 10,000. Variant-level priors were chosen for the simulation study with 14 the stringent choice of = 0.98 and setting = 10 −4 as in 2 . 15
Application to CHD and cardiovascular risk factors
16
The GWAS results used in the assessment of colocalization of CHD with related traits were 17 taken from large-scale analyses of CHD 16 (Table S1 ). All datasets had either been imputed to 1000 Genomes 14 prior to 21 GWAS analyses or were imputed up to 1000 Genomes from the summary results using DIST 47 22 (INFO>0.8). We performed colocalization analyses in two steps. In step one, we assessed 23 colocalization of CHD with the 14 risk-factors in pre-specified LD blocks from across thegenome 24 . We used a conservative variant-level prior structure with = 1 × 10 −4 and = 1 0.95, i.e. 1 in 200,000 variants are expected to be causal for two traits, and set strong bounds 2 for the regional and alignment probabilities, i.e. * = * = 0.8 so that the algorithm identified a 3 cluster of colocalized traits only if > 0.64. The full results from this analysis are available 4 at https://jrs95.shinyapps.io/hyprcoloc_chd. 5
To prioritise candidate causal genes in regions where CHD and at least one related trait 6 colocalized, we re-ran the colocalization analysis and included whole blood cis eQTL 26 (31,684 7 samples) and cis pQTL 27 (3,301 samples) data in addition to the primary traits, in a second step. 8 A colocalization analysis was performed for every transcript with data within each region. cis 9 eQTL were defined 1MB upstream and downstream of the centre of the gene probe (1,828 10 genes were analysed across the 43 regions). cis pQTL were defined 5MB upstream and 11 downstream of the transcript start site (854 proteins were analysed across the 43 regions). We 12 integrated gene expression information taken from whole blood tissue as: (i) the eQTLGen 13 dataset 26 has a large sample size relative to other publicly available gene expression data 14 resources and; (ii) the pQTL data were also measured in whole blood tissues, so there was 15 consistency in the tissue analysed. HyPrColoc first assesses evidence supporting all traits sharing an association region, which 12 quickly identifies utility in a colocalization mechanism. HyPrColoc then assesses whether any 13 shared association region is due to colocalization between the traits (criteria 1 and 2) or due to 14 a region of strong LD between two distinct causal variants, one for each trait (criterion 1 only). 15
Results from these two calculations are combined to accurately approximate the . 16 of colocalization using HyPrColoc (yellow) and MOLOC (blue) across ∈ {2,3,4} traits. 11
Where error bars are present, plotted are the 1 st , 5 th (median), and 9 th deciles. Despite differences 12 in the prior set-up between the methods, the median absolute relative difference between the 13 two posterior probabilities was ≾ 0.005. 14 scenarios presented, = 100 traits with non-overlapping samples were generated, all traits 23 had a study sample size of = 10000 and variant-level causal configuration priors were used.
In all scenarios there exists at least one cluster of 10 traits which share a causal variant, 80 traits 1 which do not have a causal variant and either: (a) the remaining traits do not have a causal 2 variant in the region; (b) there exists another cluster of 10 traits which share a distinct causal 3 variant or; (c) all remaining traits have a causal variant and these variants are 'distinct' from 4 one another (a distinct variant can be in perfect LD, i.e. 2 = 1, with another distinct variant 5 and/or the shared causal variant). In all scenarios the detection probability is presented by 6 posterior probability of colocalization, i.e.
≥ (0.6, 0.7) . Where indicated, detection 7 probabilities are presented by LD ( 2 ) between the causal variant, shared across the 10 (default) 8 colocalized traits, and any other distinct causal variant, i.e. when 2 ≤ (1, 0.95). 9 i.e. rs713782 explained over 76% of the posterior probability of colocalization whereas the 20 next candidate variant explained < 20%. 21 37 Tables   Table 1. Forty-three regions with colocalized associations across CHD and 14 related traits. Loci are sorted into three categories: (i) those known at the time of the release of CARDIoGRAMplusC4D 2015 data for CHD 16 ; (ii) those later identified in a subsequent study (or studies) or;
(iii) those that have not been previously reported and are considered future candidate CHD loci. 
